专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

US20070064207A1 PROJECTION LENS AND PORTABLE DISPLAY DEVICE FOR GAMING AND OTHER APPLICATIONS 有权
标题翻译：投影镜头和便携式显示设备，用于游戏和其他应用
公开(公告)号：US20070064207A1
公开(公告)日：2007-03-22
申请号：US11459537
申请日：2006-07-24
申请人： Ernesto Rodriguez , Patricia Hughes , Kai Lu
发明人： Ernesto Rodriguez , Patricia Hughes , Kai Lu
IPC分类号： G03B21/00
CPC分类号： G02B13/06 , G03B21/005
摘要： A portable projection device comprises a housing, a handle, and an optical engine. The optical engine comprises an illumination source, an imaging system, and a wide angle projection lens that includes a first lens group of negative refractive power, the first lens group having at least one aspheric surface, a second lens group, and a third lens group of positive refractive power. For the wide angle projection lens, the following Conditions (1) to (4) are satisfied: |F1/F|≧4.5 (Condition (1)); 2.5≦|F2/F|≦6.0 (Condition (2)); 3.8≦|F3/F|≦5.0 (Condition (3)); and 0.8≦BFL/F≦1.4 (Condition (4)). The portable projection device can be implemented as a personal gaming system and can also be configured as a portable, fully integrated video gaming system that allows gamers to plug in and play at nearly any location, with only a wall or other viewing surface being used to view the projected image.
摘要翻译：便携式投影装置包括壳体，手柄和光学引擎。光学引擎包括照明源，成像系统和广角投影透镜，其包括具有负屈光力的第一透镜组，第一透镜组具有至少一个非球面，第二透镜组和第三透镜组的正屈光力。对于广角投影透镜，满足以下条件（1）至（4）：| F 1 / F |> = 4.5（条件（1））; 2.5 <= | F 2 / F | <= 6.0（条件（2））; 3.8 <= | F 3 / F | <= 5.0（条件（3））; 和0.8 <= BFL / F <= 1.4（条件（4））。便携式投影设备可以实现为个人游戏系统，并且还可以被配置为便携式，完全集成的视频游戏系统，其允许玩家在几乎任何位置插入和播放，只有墙壁或其他观察表面被用于查看投影图像。

32. 发明申请

US20070043080A1 Substituted anilinic piperidines as MCH selective antagonists 审中-公开
标题翻译：取代的苯胺哌啶类作为MCH选择性拮抗剂
公开(公告)号：US20070043080A1
公开(公告)日：2007-02-22
申请号：US11214968
申请日：2005-08-30
申请人： Mohammad Marzabadi , John Wetzel , John DeLeon , Yu Jiang , Chien-An Chen , Kai Lu
发明人： Mohammad Marzabadi , John Wetzel , John DeLeon , Yu Jiang , Chien-An Chen , Kai Lu
IPC分类号： A61K31/445 , C07D211/26
CPC分类号： C07D401/04 , C07D211/26 , C07D211/28 , C07D211/90 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/10 , C07D471/04 , C07D495/04
摘要： This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.
摘要翻译：本发明涉及作为黑色素浓缩激素-1（MCH1）受体的选择性拮抗剂的化合物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明提供通过将治疗有效量的本发明化合物与药学上可接受的载体组合而成的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。

33. 发明申请

US20060079524A1 Amino substituted aryloxybenzylpiperidine derivatives 失效
标题翻译：氨基取代的芳氧基苄基哌啶衍生物
公开(公告)号：US20060079524A1
公开(公告)日：2006-04-13
申请号：US11230849
申请日：2005-09-20
申请人： Mohammad Marzabadi , Chien-An Chen , Yu Jiang , Kai Lu , Kim Andersen
发明人： Mohammad Marzabadi , Chien-An Chen , Yu Jiang , Kai Lu , Kim Andersen
IPC分类号： A61K31/5377 , A61K31/4545 , A61K31/496 , C07D413/14 , C07D403/14
CPC分类号： C07D211/26 , C07D211/34 , C07D401/12 , C07D403/12
摘要： This invention is directed to Amino substituted Aryloxybenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.
摘要翻译：本发明涉及作为MCH1受体的配体的氨基取代的芳氧基苄基哌啶衍生物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括向受试者施用治疗有效量的本发明化合物。本发明还提供了治疗患有肥胖症的受试者的方法，其包括向受试者施用治疗有效量的本发明化合物。

34. 发明申请

US20050245743A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof 失效
标题翻译：仲氨基苯胺哌啶类作为mch1拮抗剂及其应用
公开(公告)号：US20050245743A1
公开(公告)日：2005-11-03
申请号：US10518675
申请日：2003-07-03
申请人： Mohammad Marzabadi , Jiang Yu , Kai Lu , Chien-An Chen , John De Leon , John Wetzel
发明人： Mohammad Marzabadi , Jiang Yu , Kai Lu , Chien-An Chen , John De Leon , John Wetzel
IPC分类号： A61K31/44 , A61K31/451 , A61K31/4545 , A61K31/506 , A61P3/04 , A61P13/02 , A61P25/22 , A61P25/24 , A61P43/00 , C07D211/26 , C07D211/70 , C07D401/12 , C07D211/68 , C07D41/02 , C07D43/02
CPC分类号： C07D211/26 , C07D401/12
摘要： This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compounds of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject=s depression and/or anxiety. This invention further provides a method of treating a subject suffering from a urinary disorder.
摘要翻译：本发明涉及作为黑色素浓缩激素-1（MCH1）受体的选择性拮抗剂的化合物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明提供通过将治疗有效量的本发明化合物与药学上可接受的载体组合而成的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物与药学上可接受的载体组合。本发明还提供减少受试者体重的方法，其包括向受试者施用一定量的有效减少受试者体重的本发明化合物。本发明进一步提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括向受试者施用有效治疗受试者抑郁症和/或焦虑的量的本发明化合物。本发明还提供了治疗患有尿失禁的受试者的方法。

35. 发明申请

US20050122484A1 Projection display device with a projection module 审中-公开
标题翻译：具有投影模块的投影显示装置
公开(公告)号：US20050122484A1
公开(公告)日：2005-06-09
申请号：US11003278
申请日：2004-12-03
申请人： Ernesto Rodriguez , Patricia Hughes , William Haushalter , Kai Lu , Steven Saxe
发明人： Ernesto Rodriguez , Patricia Hughes , William Haushalter , Kai Lu , Steven Saxe
IPC分类号： G02B13/04 , G02B13/06 , G02B13/18 , G03B21/30 , G03B21/22
CPC分类号： G02B13/06 , G02B13/22 , G03B5/04 , G03B21/10 , G03B21/30 , H04N9/3141
摘要： A front projection display device having a projection module and a docking station. The docking station has a base. Further, the docking station can include an extendable arm attached to the base. The projection module contains an optical engine. The optical engine includes an illumination system, an imaging system, and a wide-angle projection lens. The optical engine outputs an image at a half field angle of at least 45°. The projected image has substantially no distortion and requires substantially no keystone correction.
摘要翻译：一种具有投影模块和对接站的前投影显示装置。对接站有一个基地。此外，对接站可以包括附接到基座的可伸展臂。投影模块包含光学引擎。光学引擎包括照明系统，成像系统和广角投影透镜。光学引擎以至少45°的半视场角输出图像。投影图像基本上没有失真，并且基本上不需要梯形失真校正。

36. 发明授权

US06727264B1 Substituted anilinic piperidines as MCH selective antagonists 失效
标题翻译：取代的苯胺哌啶类作为MCH选择性拮抗剂
公开(公告)号：US06727264B1
公开(公告)日：2004-04-27
申请号：US10188434
申请日：2002-07-03
申请人： Mohammad R. Marzabadi , John Wetzel , John E. DeLeon , Yu Jiang , Chien-An Chen , Kai Lu
发明人： Mohammad R. Marzabadi , John Wetzel , John E. DeLeon , Yu Jiang , Chien-An Chen , Kai Lu
IPC分类号： A61K31445
CPC分类号： C07D401/04 , C07D211/26 , C07D211/28 , C07D211/90 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/10 , C07D471/04 , C07D495/04
摘要： This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therepeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.
摘要翻译：本发明涉及作为黑色素浓缩激素-1（MCH1）受体的选择性拮抗剂的化合物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明提供通过将有效量的本发明化合物与药学上可接受的载体组合而成的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式